Financials

  • Market Capitalization 199.48 M
  • Employee 95
  • Founded N/A
  • CEO Daniel Vitt
  • Website www.imux.com
  • Headquarter Delaware, United States
  • FIGI BBG001M75SX4
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-4.34
ratio cours/chiffre d'affaires

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
3587
CUE
Cue Biopharma, Inc. - Common Stock
28.42 USD+11.36%+6.20%+5.26%+3452.50%206.45 M USD
3597
ORMP
Oramed Pharmaceuticals Inc. - Common Stock
4.85 USD-3.39%-6.91%+18.00%+126.64%201.75 M USD
3610
IPHA
Innate Pharma S.A. - American Depositary Shares
2.12 USD-2.30%-4.50%+21.14%+1.92%198.68 M USD
3613
ACOG
Alpha Cognition Inc. - Common Stock
9.16 USD-1.19%-6.05%+11.57%+9.96%199.49 M USD

Nouvelles